ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,035Medicare Part D Prescriptions Filled, Including Refills

Rank: 440 out of 6969

$589K Total Retail Price of All Prescriptions

Rank: 414 out of 6969

631 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
97% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

7% of this provider’s 631 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 9,510 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

39% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
SIMVASTATIN 466 447 1 1
AMLODIPINE BESYLATE 327 316 2 4
OMEPRAZOLE 262 247 3 6
TAMSULOSIN HCL 242 237 4 23
DIOVAN 233 224 5 26
DIOVAN HCT 220 209 6 57
FUROSEMIDE 215 209 7 10
LEVOTHYROXINE SODIUM 212 212 8 5
METOPROLOL SUCCINATE 202 201 9 22
CRESTOR 200 194 10 39
METOPROLOL TARTRATE 176 159 11 13
MELOXICAM 175 169 12 36
METFORMIN HCL 172 165 13 7
ALENDRONATE SODIUM 171 152 14 14
ATORVASTATIN CALCIUM 166 161 15 11
TRAMADOL HCL 165 141 16 27
FAMOTIDINE 164 162 17 37
ZOLPIDEM TARTRATE 149 127 18 16
ACTOS 149 148 18 61
MECLIZINE HCL 128 127 20 100
GABAPENTIN 119 106 21 17
CARVEDILOL 115 109 22 25
NORTRIPTYLINE HCL 114 113 23 140
LIPITOR 113 104 24 89
LOSARTAN POTASSIUM 113 108 24 12
NEXIUM 109 97 26 52
ATENOLOL 106 103 27 9
WARFARIN SODIUM 106 98 27 20
DONEPEZIL HCL 103 96 29 32
PANTOPRAZOLE SODIUM 103 103 29 31
LOSARTAN-HYDROCHLOROTHIAZIDE 102 98 31 53
VOLTAREN 101 94 32 105
PLAVIX 101 100 32 68
GLYBURIDE-METFORMIN HCL 99 92 R 34 92
SYMBICORT 93 93 35 149
SERTRALINE HCL 84 63 36 38
CLOPIDOGREL 83 78 37 48
ZETIA 83 83 37 98
LIDODERM 81 71 39 75
PAROXETINE HCL 77 77 40 65
AVODART 74 74 41 108
HYDROCODONE-ACETAMINOPHEN 73 59 S3 42 3
PRAVASTATIN SODIUM 73 69 42 19
RANITIDINE HCL 71 70 44 46
SPIRIVA 70 63 45 66
BENAZEPRIL HCL 68 68 46 18
AZITHROMYCIN 62 57 47 42
SINGULAIR 61 61 48 84
ALLOPURINOL 61 61 48 35
HYDRALAZINE HCL 58 57 50 106
PIOGLITAZONE HCL 57 56 R 51 174
LISINOPRIL 56 56 52 2
ESCITALOPRAM OXALATE 56 46 52 93
ADVAIR DISKUS 56 56 52 45
NAMENDA 56 51 52 51
LEVOFLOXACIN 54 48 56 109
SPIRONOLACTONE 54 47 56 102
JANUVIA 53 48 58 41
DILTIAZEM 24HR CD 52 52 59 191
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 4, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.